doi: 10.1111/j.1365-2559.2005.02186.x.
Serous borderline tumours of the ovary
Affiliations
- PMID: 16115232
- DOI: 10.1111/j.1365-2559.2005.02186.x
Item in Clipboard
Serous borderline tumours of the ovary
Histopathology.
2005 Sep.
Abstract
Serous borderline tumours of the ovaryIn this Expert Opinion we have invited articles from two leading groups, to discuss serous borderline tumours (serous tumours of low malignant potential) of the ovary from their own perspectives. Controversy remains over heterogeneity within this group of tumours and their relationship to ovarian cancer. Our authors discuss the histopathological classification of these tumours in relation to morphological appearances, molecular and clinical data. The significance of a micropapillary pattern is discussed, and issues related to extra-ovarian implants.
Similar articles
-
A multistep model for ovarian tumorigenesis: the value of mutation analysis in the KRAS and BRAF genes.J Pathol. 2004 Jun;203(2):617-9. doi: 10.1002/path.1563. J Pathol. 2004. PMID: 15141374
-
In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.J Pathol. 2004 Mar;202(3):336-40. doi: 10.1002/path.1521. J Pathol. 2004. PMID: 14991899
-
The pathology of and controversial aspects of ovarian borderline tumours.Curr Opin Oncol. 2010 Sep;22(5):462-72. doi: 10.1097/CCO.0b013e32833b0dc1. Curr Opin Oncol. 2010. PMID: 20531187 Review.
-
KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.Gynecol Oncol. 2006 Dec;103(3):883-7. doi: 10.1016/j.ygyno.2006.05.029. Epub 2006 Jun 30. Gynecol Oncol. 2006. PMID: 16806438
-
Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges.Clin Cancer Res. 2005 Oct 15;11(20):7273-9. doi: 10.1158/1078-0432.CCR-05-0755. Clin Cancer Res. 2005. PMID: 16243797 Review.
Cited by
-
Whole exome sequence analysis of serous borderline tumors of the ovary.Gynecol Oncol. 2013 Sep;130(3):560-4. doi: 10.1016/j.ygyno.2013.06.007. Epub 2013 Jun 14. Gynecol Oncol. 2013. PMID: 23774303 Free PMC article.
-
Biomarker expression in normal fimbriae: Comparison of high- and low-grade serous ovarian carcinoma.Oncol Lett. 2012 Nov;4(5):1008-1012. doi: 10.3892/ol.2012.877. Epub 2012 Aug 23. Oncol Lett. 2012. PMID: 23162641 Free PMC article.
-
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants.BMC Cancer. 2013 Oct 18;13:483. doi: 10.1186/1471-2407-13-483. BMC Cancer. 2013. PMID: 24139521 Free PMC article.
-
Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.BMC Cancer. 2008 Nov 26;8:346. doi: 10.1186/1471-2407-8-346. BMC Cancer. 2008. PMID: 19032793 Free PMC article.
-
Risk factors for recurrence of ovarian borderline tumors.Gynecol Oncol. 2011 Mar;120(3):480-4. doi: 10.1016/j.ygyno.2010.11.016. Epub 2010 Dec 10. Gynecol Oncol. 2011. PMID: 21146201 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
